Catalent Orally Inhaled & Nasal Drug Delivery Solutions
Information
With over 30 years of experience supporting the development of inhaled products and full commercial-scale manufacturing capabilities, Catalent offers complete, end-to-end solutions across all common inhalation dose forms, including DPIs, MDIs, and unit/bi-dose nasal sprays. From early development and device selection through clinical supply, commercial production, packaging, and final product testing, Catalent provides comprehensive inhalation services to help bring more products and better treatments to market faster.
Key learning objectives:
- Understand the latest trends in orally and nasally inhaled therapeutics
- Learn about Catalent's end-to-end inhalation manufacturing and development services
- Why partner with Catalent for your inhalation products
